Iowa Senate race centers on cancer rates as Turek and Hinson compete

The Iowa Senate race for the seat vacated by retiring Republican Sen. Joni Ernst has quickly become one of the most fiercely contested contests of the cycle. Democratic state legislator Josh Turek is challenging incumbent Republican Rep. Ashley Hinson, and both candidates are sharpening their campaigns around the state’s alarming cancer statistics, which have drawn national attention. Iowa’s high rate of cancer diagnoses—particularly in rural counties—has become a central theme, with Turek arguing that new federal health initiatives could bring much-needed resources to the state, while Hinson stresses her record of securing state funding for local medical facilities.

The race has attracted significant attention from both parties, as analysts note that the district’s demographic shifts and recent voter turnout trends could tip the balance. Hinson, who has served in the U.S. House since 2019, emphasizes her experience in federal budgeting and her ties to the agricultural community, while Turek, a former state lawmaker, positions himself as a fresh voice ready to address public health and economic concerns. Both candidates have pledged to expand access to cancer screening and treatment, but they differ on the extent of federal involvement and the allocation of state resources.

As the campaign season heats up, the focus on cancer care underscores a broader debate over healthcare policy in Iowa. With the election set for November, the outcome will not only determine who holds the Senate seat but may also signal the state’s willingness to adopt more aggressive health initiatives. The race remains a key indicator of how Iowa’s voters will balance experience against new policy priorities in the coming election.